KOE · 420770.KQ
GigaVis Co., Ltd.
₩93,000-₩11,400 (-10.92%)
GigaVis Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 54.85% below the high.
Loading market information…
KOE · 102940.KQ · KRW
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 06:30 AM UTC. Cached market data; not a live quote.
One-year closing-price history · KRW. Historical prices are not a forecast.
Kolon Life Science Inc.’s quoted price sits in the lower half of its reported 52-week range, 82.93% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Kolon Life Science Inc.’s forward annual dividend is ₩200 per share, paid annual. The forward yield is 1.61% at the quoted price. Future payments can change.
Dividend payment history is currently unavailable.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Kolon Life Science Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Kolon Life Science Inc. is primarily engaged in the creation and distribution of pharmaceutical products and environmental materials. The company's operations are organized into two distinct units: Chemical and Bio. Its Chemical division manages both pharmaceutical activities and the development of specialty chemicals. In contrast, the Bio business unit is focused on providing contract development and manufacturing services for biopharmaceuticals. The enterprise was founded on April 21, 2000, and its corporate headquarters are situated in Seoul, South Korea.
Latest available per-share figures in KRW. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 12:29 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
₩93,000-₩11,400 (-10.92%)
GigaVis Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 54.85% below the high.
₩52,700-₩4,000 (-7.05%)
Intellian Technologies, Inc.’s quoted price sits in the lower half of its reported 52-week range, 70.75% below the high.
₩19,130-₩970 (-4.83%)
Dongwoon Anatech Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 66.08% below the high.
₩18,470-₩1,140 (-5.81%)
AbClon Inc.’s quoted price sits in the lower half of its reported 52-week range, 80.72% below the high.
₩16,470-₩740 (-4.3%)
Neuromeka Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 82.23% below the high.
₩11,970-₩720 (-5.67%)
T-Robotics.Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 61.26% below the high.
₩3,200-₩210 (-6.16%)
Bio Plus Co., Ltd’s quoted price sits in the lower half of its reported 52-week range, 51.0% below the high.
₩10,100+₩350 (+3.59%)
Gc Cell Corp.’s quoted price sits in the lower half of its reported 52-week range, 64.5% below the high.
